8–11:50 a.m.
From Bench to Bedside: PCI for ACS, STEMI and Shock
Moderators: Mina Madan, Toronto, Ontario, Canada, George D. Dangas, New York, N.Y., Sunil V. Rao, Durham, N.C., Roxana Mehran, New York, N.Y., Philippe Steg, Paris, France, Timothy Henry, Minneapolis, Minn., Cindy L Grines, Royal Oak, Mich.

Welcome and Introduction
Harry Dauerman, Burlington, Vt.

Session I: PCI and ACS: Genetics, Pharmacology and Timing
Defining a Best PCI for ACS Pharmacology: Recent Trials and Guidelines - Gilles Montalescot, Paris, France

Genetics, Resistance and Antiplatelet Therapies: Implications for Clinicians - Matthew Price, La Jolla, Calif.

New Pharmacologies Undergoing Investigation: What’s On the Horizon? - Richard Becker, Durham, N.C.

A High Risk ACS Case Review: The Elderly Woman with Renal Failure - Sunil V Rao, Durham, N.C.

Panel Discussion: Mina Madan, Toronto, Ontario, Canada, Deepak Bhatt, Boston, Mass., Harvey White, Auckland, New Zealand and George D Dangas, New York, N.Y.

Session II: PCI for STEMI: Devices, Drugs and Systems
STEMI Anticoagulation and Stent Options: What Have We Learned in the Past Two Years? - David Holmes, Rochester, Minn.

Mission Lifeline and D2B: Are We Getting Better and Saving More Lives? - Alice K Jacobs, Boston, Mass.

A Transfer STEMI Case Review: Systems and Pharmacology - Philippe Steg, Paris, France

Panel Discussion: Dariusz Dudek, Krakow, Poland, Christopher B. Granger, Durham, N.C., Harry Dauerman, Burlington, Vt., and Roxana Mehran, New York, N.Y.

Session III: PCI for Cardiogenic Shock: Inflammation, Outcomes and Standard of Care
Percutaneous Left Ventricular Assist Devices: Current Indications for Use - Jose Henriques, Amsterdam, Netherlands

PCI for Cardiogenic Shock in the Young and the Elderly: Estimating the Risk and Benefit from Trials and Registries - Erik Magnus Ohman, Durham, N.C.

An Elderly Patient, Anterior MI and Shock: A Case Review to Define Current Standard of Care - Timothy Henry, Minneapolis, Minn.

Panel Discussion: Melchior Seyfarth, Muenchen, Germany, Simon Dixon, Royal Oak, Mich., Srihari Naidu, Mineola, N.Y., and Cindy L. Grines, Royal Oak, Mich.

3:45–5 p.m.
Advanced Coronary Interventions II: Left Main and Bifurcation Lesions
Moderator: Thierry Lefèvre, Massy, France and Peter Berger, Danville, Pa.

Does SYNTAX Open the Door to Routine LM Intervention? - Marie Morice, Massy, France

Does Stent Type Matter in LM Interventions? - Julinda Mehilli, Munich, Germany

Bifurcation PCI: Case Presentation and Optimal Technique - Antonio Colombo, Milano, Italy

Left Main PCI: Case Presentation and Optimal Technique - Paul S Teirstein, La Jolla, Calif.

5:30-6:45 p.m.M
Controversies in Carotid and Renal Interventions
Moderator: Kenneth Rosenfield, Boston, Mass.

Prevalence and Prognosis of Asymptomatic Carotid Artery Stenosis: What We Know and What’s Missing? - Joshua A Beckman, Boston, Mass.

Symptomatic Carotoid Disease: Stents or Surgery in 2009? - William A Gray, New York, N.Y.

Should the ASTRAL Trial Be the End of Renal Interventions? - Philip A Kalra, Salford, United Kingdom